期刊文献+

河北省1989-2013年HIV/AIDS死亡与HAART关系的分析 被引量:5

Effect of highly active anti-retroviral therapy on reducing HIV/AIDS related death in Hebei,1989-2013
原文传递
导出
摘要 目的 了解河北省HIV/AIDS的HAART效果.方法 以1989-2013年全省报告的4 148例HIV/AIDS进行研究,对发现的HIWAIDS定期随访、检测CD4+T淋巴细胞计数、登记死亡.自2003年开始,对符合HAART条件的HIV/AIDS实施免费治疗.观察截止日期为2013年12月31日.结果 4 148例HIV/AIDS,观察12 451.48人年,全死因死亡968例,死亡密度7.77/100人年,其中接受HAART者死亡密度为2.87/100人年,未接受HAART者死亡密度为16.58/100人年,后者是前者的5.77倍.对1 894例AIDS,自发病之日至观察截止日,观察4 774.48人年,全死因死亡581例,死亡密度121.69/100人年,其中参加HAART者死亡密度4.77/100人年,未参加HAART者死亡密度125.92/100人年.CD4+T淋巴细胞计数<200 cells/mm^3组的死亡密度由不接受HAART治疗的22.9/100人年降至接受HAART治疗的5.3/100人年.通过年度分析发现,随着HIV/AIDS人群HAART覆盖率逐年提高,人群的全死因死亡率逐年下降.HIV人群HAART覆盖率提高,可降低未参加HAART的HIV感染者的死亡率.结论 进一步扩大抗病毒治疗覆盖面,可有效减少HIV/AIDS的死亡. Objective To investigate the effect of highly active anti-retroviral therapy (HAART) on reducing HIV/AIDS related death.Methods The analysis was conducted by using the data of 4 148 HIV/AIDS cases reported in Hebei province from 1989 to 2013.Regular follow-up,CD4 detection,registration of death were carried out for them.Free HAART has been provided to people living with HIV/AIDS who met the treatment requirement since 2003.Results Of 4 148 HIV/AIDS cases,12 451.48 person years were observed,968 cases died due to all registered death causes.The death density was 7.77/100 person years.The death density was 2.87/100 person years for the HIV/AIDS cases receiving HAART,and 16.58/100 for the HIV/AIDS cases receiving no HAART.In 1 894 AIDS cases,a total of 4 774.48 person years were observed from onset to death,581 cases died due to all registered death causes,and the death density was 121.69/100 person years.The death density was 4.77/100 person years for the cases receiving HAART,and 125.92/100 person years for the cases receiving no HAART.In the cases with CD less than 200/mm^3,the death density was 22.9/ 100 person years for those receiving no HAART and 5.3/100 person years for those receiving HAART.The annual analysis found that the death rate due to all registered death causes declined as the increase of HAART coverage in people living with HIV/AIDS.The expanding of HAART coverage in people infected with HIV can reduce death rate among them.Conclusion Further expanding of HAART can effectively reduce the death among people living with HIV/AIDS.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2015年第5期460-464,共5页 Chinese Journal of Epidemiology
基金 河北省科技支撑计划(11276103D-11)
关键词 艾滋病病毒感染/艾滋病患者 高效联合抗反转录病毒治疗 全死因死亡 死亡率 死亡密度 HIV/AIDS Highly active anti-retrovial therapy All causes of death Mortality Death density
  • 相关文献

参考文献7

  • 1Mills E J, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda [J]. Ann Intern Med, 2011,155(4) :206-216.
  • 2Cohen MS, Chen YQ,McCauley M,et al. Prevention of HIV-1 infection with early antiretroviral therapy[ J]. N Engl J Med, 2011, 365 (6) :493-505.
  • 3陈素良,储俊武,李保军,王林,赵宏儒,宋爱军,赵翠英,邢辉,白广义,张玉琪,邵一鸣.中国某县既往有偿供血者HIV感染追踪监测[J].中国艾滋病性病,2010,16(4):337-340. 被引量:7
  • 4Himschall G. Director, Department of HIV/AIDS. Closing the HIV services gap [R/OL]. (2014-08-27). http://www.who.int/ mediacentre/commentaries/hiv/en/.
  • 5陈素良,张玉琪,赵宏儒,陈志强,李保军,赵翠英,白广义,梁良,王伟.受血和有偿供血HIV感染患者HAART效果的比较[J].中华实验和临床病毒学杂志,2012,26(4):291-294. 被引量:2
  • 6杨跃诚,段松,项丽芬,叶润华,龚渝蓉,杨世江,高洁,杨忠桔,韩文香,李洲林,濮永成,杨建华,曹东冬,李维美,何纳.云南省德宏州1989--2011年HIV感染者死亡率及其影响因素研究[J].中华流行病学杂志,2012,33(10):1026-1030. 被引量:29
  • 7Dou Z, Chert RY, Wang Z, et al. HIV-infected former plasma donorsin rural Central China:from infection to survival outcomes, 1985-2008[J]. PLoS One,2010,5(10) :e13737.

二级参考文献21

  • 1邵一鸣,赵全壁,王斌,陈筝,苏玲,曾毅,赵尚德,张家鹏,段一娟.我国云南德宏地区HIV感染者HIV毒株膜蛋白基因的序列测定和分析[J].病毒学报,1994,10(4):291-299. 被引量:51
  • 2陈素良,张志坤,赵勇,邓金华,李桂银,石磊,田万春,池良增,杨愈通,庄辉,钱会霖,柳朝藩.单采血浆还输血细胞献血员中疟疾感染的流行病学调查[J].中华预防医学杂志,1994,28(6):350-352. 被引量:20
  • 3尹可丽.傣族佛教信徒皈依行为的原因及意义[J].云南师范大学学报(哲学社会科学版),2006,38(5):42-46. 被引量:7
  • 4李峰,臧镭镭,黄焕光,周彭城,魏鹤鹤,宋月晗,关静,王佳,潘鸿贵,覃永康.广西部分地区1030例药物滥用者人口学和药物滥用情况调查[J].中国药物依赖性杂志,2006,15(6):464-471. 被引量:10
  • 5马瑛 李祖正.首次在我国吸毒人群中发现艾滋病病毒感染者[J].中华流行病学杂志,1990,11(3):184-185.
  • 6Dou Z, Chen RY, Wang Z, et al. HIV-Infected Former Plasma Donors in Rural Central China: From Infection to Survival Outcomes, 1985-2008. PLoS ONE,2010,5: e13737.
  • 7Obels N, Omland LH, Kronborg G, et al. Impact of Non-HIV and HIV Risk Factors on Survival in HlV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study. PLoS ONE, 2011,6:1-6.
  • 8Mills EJ, Bakanda C, Birungi J, et al. Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low- Income Countries: A Cohort Analysis From Uganda. American College of Physicians, 2011,155 : 209-216.
  • 9Lodwick RK, Sabin CA, Porter K, et al. Death rates in HIV- positive antiretroviral-naive patients with CIM count greater than 350 cells per mieroL in Europe and North America: a pooled cohort observational study. Lancet,2010,376:340-345.
  • 10Dou Z,Chen RY, Wang Z, et al. HIV-infected former plasmadonors in Rural Central China: from infection to survivaloutcomes, 1985-2008. PLoS One,2010,5( 10) :el3737.

共引文献34

同被引文献46

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部